Source: Contraception. Unidade: FMRP
Subjects: ANTICONCEPÇÃO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, DISPOSITIVOS INTRAUTERINOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRACHE, Vivian et al. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study. Contraception, v. 104, n. 4, p. 327-336, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2021.06.010. Acesso em: 06 jan. 2026.APA
Brache, V., Vieira, C. sales, Plagianos, M., Lansiaux, M., Merkatz, R., Sussman, H., et al. (2021). Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study. Contraception, 104( 4), 327-336. doi:10.1016/j.contraception.2021.06.010NLM
Brache V, Vieira C sales, Plagianos M, Lansiaux M, Merkatz R, Sussman H, Cochon L, Tejada AS, Kumar N, Loeven D, Blithe DL, Aprem AS, Williams AR, Kannan A, Bagchi IC, Sitruk-Ware R. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study [Internet]. Contraception. 2021 ; 104( 4): 327-336.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1016/j.contraception.2021.06.010Vancouver
Brache V, Vieira C sales, Plagianos M, Lansiaux M, Merkatz R, Sussman H, Cochon L, Tejada AS, Kumar N, Loeven D, Blithe DL, Aprem AS, Williams AR, Kannan A, Bagchi IC, Sitruk-Ware R. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study [Internet]. Contraception. 2021 ; 104( 4): 327-336.[citado 2026 jan. 06 ] Available from: https://doi.org/10.1016/j.contraception.2021.06.010
